Inhibition of postprandial hyperglycemia by acarbose is a promising therapeutic strategy for the treatment of patients with the metabolic syndrome (Q46489585)
scientific article published on 28 January 2005
Language:
other details
description scientific article published on 28 January 2005

External Links